Partial adenosine A1 receptor agonists inhibit sarin-induced epileptiform activity in the hippocampal slice

European Journal of Pharmacology

Volumn 471, Issue 2, 2003, Pages 97-104

  Harrison, Patrick K ^a   Bueters, Tjerk J H ^b   Ijzerman, Adriaan P ^c   Van Helden, Herman P M ^b   Tattersall, John E H ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b TNO   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

(Guinea pig); Adenosine; Epileptiform; Hippocampal slice; Organophosphate; Sarin

Indexed keywords

1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; 2 DEOXY N 6 CYCLOPENTYLADENOSINE; 2' DEOXY N6 CYCLOPENTYLADENOSINE; 2'-DEOXY-N6-CYCLOPENTYLADENOSINE; 6 N CYCLOPENTYLADENOSINE; 8 BUTYLAMINO N 6 CYCLOPENTYLADENOSINE; 8 BUTYLAMINO N(6) CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 8-BUTYLAMINO-N(6)-CYCLOPENTYLADENOSINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE DERIVATIVE; DEOXYADENOSINE DERIVATIVE; DRUG DERIVATIVE; PARTIAL AGONIST; SARIN; SOMAN; UNCLASSIFIED DRUG; XANTHINE DERIVATIVE;

ACTION POTENTIAL; ANIMAL; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLOGY; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; EPILEPTIC DISCHARGE; GUINEA PIG; HIPPOCAMPUS; IATROGENIC DISEASE; IC 50; MALE; MICROELECTRODE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SEIZURE; STRUCTURE ACTIVITY RELATION;

EID: 0038005503     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01783-7     Document Type: Article

References (45)

1. Alzheimer C., Sutor B., ten Bruggencate G. Transient and selective blockade of adenosine A1-receptors by 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) causes sustained epileptiform activity in hippocampal CA3 neurons of guinea pigs. Neurosci. Lett. 99:1989;107-112.
2. 1 receptors very similar to those of peripheral tissues. Eur. J. Pharmacol. 196:1991;313-317.
3. Anderson D.R., Harris L.W., Chang F.C.T., Baze W.B., Capacio B.R., Byers S.L., Lennox W.J. Antagonism of soman-induced convulsions by midazolam, diazepam and scopolamine. Drug Chem. Toxicol. 20:1997;115-131.
4. Apland J.P. Anticonvulsant drugs block soman-induced epileptiform activity in guinea pig hippocampal-entorhinal cortex slices. Soc. Neurosci. Abstr. 26:2000;662.16.
5. Ault B., Wang C.M. Adenosine inhibits epileptiform activity arising in hippocampal area CA3. Br. J. Pharmacol. 87:1986;695-703.
6. Bakry N.M.S., El-Rashidy A.H., Eldefrawi A.T., Eldefrawi M.I. Direct actions of organophosphate anticholinesterases on nicotinic and muscarinic acetylcholine receptors. J. Biochem. Toxicol. 3:1988;235-259.
7. Bernado L.S., Prince D.A. Cholinergic excitation of mammalian hippocampal pyramidal cells. Brain Res. 249:1982;315-331.
8. Bragdon A.C., Taylor D.M., Wilson W.A. Potassium-induced epileptiform activity in area CA3 varies markedly along the septotemporal axis of the rat hippocampus. Brain Res. 378:1986;169-173.
9. 14C]Acetylcholine release from rat cortex. J. Pharmacol. Exp. Ther. 277:1996;193-197.
10. Bueters T.J.H., Groen B., Danhof M., Ijzerman A.P., Van Helden H.P.M. Therapeutic efficacy of the adenosine A(1) receptor agonist N(6)-cyclopentyladenosine (CPA) against organophosphate intoxication. Arch. Toxicol. 76:2002;650-656.
11. Bueters T.J.H., Van Helden H.P.M., Ijzerman A.P., Danhof M. Low efficacy adenosine A1 agonists inhibit striatal acetylcholine release in rats, improving central selectivity of action. Neurosci. Lett. 2003;. (in press).
12. Chesi A.J.R., Stone T.W. Alkylxanthine adenosine antagonists and epileptiform activity in rat hippocampal slices in vitro. Exp. Brain Res. 113:1997;303-310.
13. Cole A.E., Nicholl R.A. Characterization of a slow cholinergic post-synaptic potential recorded in vitro from rat hippocampal pyramidal cells. J. Physiol. (London). 352:1984;173-188.
14. Dunwiddie T.V. Adenosine and suppression of seizures. Jasper's Basic Mechanisms of the Epilepsies. 3rd ed. Advances in Neurology. vol. 79:1999;1001-1010 Lippincott Williams and Wilkins, Philadelphia.
15. Dunwiddie T.V., Diao L. Extracellular adenosine concentrations in hippocampal brain slices and the tonic inhibitory modulation of evoked excitatory responses. J. Pharmacol. Exp. Ther. 268:1994;537-545.
16. Endres W., Spuler A., ten Bruggencate G. Acetylcholinesterase reactivators antagonize epileptiform bursting induced by paraoxon in guinea-pig hippocampal slices. J. Pharmacol. Exp. Ther. 251:1989;1181-1186.
17. Harrison P.K., Sheridan R.D., Green A.C., Scott I.R., Tattersall J.E.H. Development of a guinea-pig hippocampal slice model of soman-induced seizure activity. Eur. J. Neurosci. 12:2000;209. (Supplement).
18. Harrison P.K., Sheridan R.D., Green A.C., Tattersall J.E.H. Spectrum of anticonvulsant activity against soman-induced bursting in the guinea-pig in vitro hippocampus. Br. J. Pharmacol. 134:2001;125P. (Supplement).
19. Hayward I.J., Wall H.G., Jaax N.K., Wade J.V., Marlow D.D., Nold J.B. Decreased brain pathology in organophosphate-exposed rhesus monkeys following benzodiazepine therapy. J. Neurol. Sci. 98:1990;99-106.
20. Jin S., Fredholm B.B. Adenosine A1 receptors mediate hypoxia-induced inhibition of electrically evoked transmitter release from rat striatal slices. Eur. J. Pharmacol. 329:1997;107-113.
21. Kasa P. The cholinergic systems in brain and spinal cord. Prog. Neurobiol. 26:1986;211-272.
22. Kenakin T. Agonist-receptor efficacy: 2. Agonist trafficking of receptor signals. Trends Pharmacol. Sci. 16:1995;232-238.
23. Kirkpatrick K.A., Richardson P.J. Adenosine receptor-mediated modulation of acetylcholine release from rat striatal synaptosomes. Br. J. Pharmacol. 110:1993;949-954.
24. 1 agonists with diminished hypotensive effects. J. Med. Chem. 42:1999;3463-3477.
25. Lallement G., Dorandeu F., Filliat P., Carpientier P., Baille V., Blanchet G. Medical management of organophosphate-induced seizures. J. Physiol. (Paris). 92:1998;369-373.
26. Lau W.M., Freeman S.E., Szilagyi M. Binding of some organophosphate compounds at adenosine receptors in guinea pig brain membranes. Neurosci. Lett. 94:1988;125-130.
27. Leadbeater L., Inns R.H., Rylands J.M. Treatment of poisoning by soman. Fundam. Appl. Toxicol. 5:1985;S225-S231.
28. Lewis P.R., Shute C.C.D., Silver A. Confirmation from choline acetylase activity of a massive cholinergic innervation of the rat hippocampus. J. Physiol. (London). 191:1967;215-224.
29. 1 receptors. Eur. J. Pharmacol. 334:1997;299-307.
30. Mathot R.A.A., Van der Wenden E.M., Soudijn W., Ijzerman A.P., Danhof M. Deoxyribose analogs of N-6-cyclopentyladenosine (CPA) - partial agonists at the adenosine A(1) receptor in vivo. Br. J. Pharmacol. 116:1995;1957-1964.
31. McDonough J.H., McLeod C.G., Nipwoda M.T. Direct microinjection of soman or VX into the amygdala produces repetitive limbic convulsions and neuropathology. Brain Res. 435:1987;123-137.
32. McDonough J.H., Zoeffel L.D., McMonagle J., Copeland T.L., Smith C.D., Shih T.M. Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs. Epilepsy Res. 38:2000;1-14.
33. Muller W., Misgeld U. Slow cholinergic excitation of guinea pig hippocampal neurons is mediated by two muscarinic subtypes. Neurosci. Lett. 67:1986;107-112.
34. Niijima H., Nagao M., Nakajima M., Takatori T., Matsuda Y., Iwase H., Kobayashi M. Sarin-like and soman-like organophosphorous agents activate PLCγ in rat brains. Toxicol. Appl. Pharmacol. 156:1999;64-69.
35. Piredda S., Gale K. A crucial epileptogenic site in the deep prepiriform cortex. Nature. 317:1985;623-625.
36. Rocha E.S., Chebabo S.R., Santos M.D., Aracava Y., Albuquerque E.X. An analysis of low level doses of cholinesterase inhibitors in cultured neurons and hippocampal slices of rats. Drug Chem. Toxicol. 21:1998;191-200.
37. 1 receptors. J. Med. Chem. 39:1996;1463-1471.
38. Santos M.D., Pereira E.F.R., Aracava Y., Castro N.G., Fawcett W.P., Randall W.R., Albuquerque E.X. Low concentrations of pyridostigmine prevent soman-induced inhibition of GABAergic transmission in the central nervous system: involvement of muscarinic receptors. J. Pharmacol. Exp. Ther. 304:2003;254-265.
39. Shih T.M., McDonough J.H. Neurochemical mechanisms in soman-induced seizures. J. Appl. Toxicol. 17:1997;255-264.
40. Shih T.M., McDonough J.H. Organophosphorus nerve agents-induced seizures and efficacy of atropine sulfate as anticonvulsant treatment. Pharmacol. Biochem. Behav. 64:1999;147-153.
41. Van der Wenden E.M., Frijtag Drabbe Kunzel J.K., Mathot R.A.A., Danhof M., Ijzerman A.P., Soudijn W. Ribose-modified adenosine analogues as potential partial agonists for the adenosine receptor. J. Med. Chem. 38:1995;4000-4006.
42. Van Helden H.P.M., Bueters T.J.H. Protective activity of adenosine receptor agonists in the treatment of organophosphate poisoning. Trends Pharmacol. Sci. 20:1999;438-440.
43. Van Helden H.P.M., Groen B., Moor E., Westerink B.H.C., Bruijnzeel P.L.B. New generic approach to the treatment of organophosphate poisoning: adenosine mediated inhibition of ACh release. Drug Chem. Toxicol. 21:1998;171-181.
44. Van Schaick E.A., Mathot R.A.A., Gubbens Stibbe J.M., Langemeijer M.W.E., Roelen H.C.P.F., Ijzerman A.P., Danhof M. 8-Alkylamino-substituted analogs of N-6-cyclopentyladenosine are partial agonists for the cardiovascular adenosine A(1) receptors in vivo. J. Pharmacol. Exp. Ther. 283:1997;800-808.
45. Wolthuis O.L., Van Helden H.P.M., Melchers B.P.C., Busker R.W., De Groot D.M.G. Search for a therapy against soman-intoxication. Neurosci. Behav. Rev. 18:1994;469-484.